品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | C129474-5mg | 5mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, ≥98% |
|
|
阿拉丁 | C129474-10mg | 10mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, ≥98% |
|
|
阿拉丁 | C129474-50mg | 50mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, ≥98% |
|
|
阿拉丁 | C129474-1mg | 1mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, ≥98% |
|
|
阿拉丁 | C129474-25mg | 25mg | 期货,请咨询 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, ≥98% |
|
|
阿拉丁 | C129474-100mg | 100mg | 期货,请咨询 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, ≥98% |
|
|
阿拉丁 | C409131-1ml | 1ml | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
Moligand™, 10mM in DMSO |
|
|
麦克林 | C872327-1mg | 1mg | 订前询问 | 1257704-57-6 |
CEP-33779 CEP-33779 |
0.99 |
|
|
罗恩 | R029954-1mg | 1mg | 现货 | 1257704-57-6 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲... CEP-33779 |
99% |
|
|
MARY | MR13101065-1mg | 1mg | 订前咨询 | 1257704-57-6 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲... CEP-33779 |
99% |
|
|
源叶 | S80234-1mg | 1mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
99% |
|
|
源叶 | S80234-5mg | 5mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
99% |
|
|
源叶 | S80234-10mg | 10mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
99% |
|
|
源叶 | S80234-25mg | 25mg | 现货 | 1257704-57-6 |
CEP-33779 CEP-33779 |
99% |
|
|
源叶 | S80234-50mg | 50mg | 期货,请咨询 | 1257704-57-6 |
CEP-33779 CEP-33779 |
99% |
|
|
源叶 | S80234-100mg | 100mg | 期货,请咨询 | 1257704-57-6 |
CEP-33779 CEP-33779 |
99% |
|
|
源叶 | T93204-1ml | 1ml | 期货,请咨询 | 1257704-57-6 |
CEP-33779 CEP-33779 |
10mM in DMSO |
|
|
毕得 | BD304681-5mg | 5mg | 现货 | 1257704-57-6 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲... N-(3-(4-Methylpiperazin-1-yl... |
99% |
|
|
毕得 | BD304681-10mg | 10mg | 现货 | 1257704-57-6 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲... N-(3-(4-Methylpiperazin-1-yl... |
99% |
|
|
毕得 | BD304681-50mg | 50mg | 现货 | 1257704-57-6 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲... N-(3-(4-Methylpiperazin-1-yl... |
99% |
|
|